Despite several studies demonstrating the efficacy of ATF6 in mitigating AMI injury, the mechanism of how ATF6, an ER-resident transcription factor, could protect from reperfusion damage associated with AMI or stroke, most of which is caused by oxidative stress and ROS generated by mitochondria, remained elusive. The gene discussed is ATF6; the disease is Stroke.